Previous 10 | Next 10 |
Recro Pharma (REPH): Q3 GAAP EPS of -$0.09 beats by $0.11.Revenue of $19.29M (-23.6% Y/Y) beats by $2.96M.Press Release For further details see: Recro Pharma EPS beats by $0.11, beats on revenue
Company Secures Three-Year Renewal of Licens e and Supply Agreement with Lannett , A Generic s Pharmaceutical Company, for Manufacturing of Verelan PM ® , Verelan SR ® and Verapamil PM Strong Technical Perform...
BXRX has been pummeled since the start of the pandemic dropping from the high $7s to the low $1s. In this article, I review the company developments, both negative and positive, that have transpired during the period. In weighing the pros and cons, I conclude that while the develo...
MALVERN, Pa., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for formulation, analytical services, regulatory support, manufacturing and packaging of both commercial and deve...
GAINESVILLE, Ga., Sept. 18, 2020 (GLOBE NEWSWIRE) -- Recro (Nasdaq:REPH), a leading contract development and manufacturing organization (CDMO), with integrated solutions for the development, formulation, regulatory support, manufacturing and packaging of oral solid dose drug products, today...
Recro Pharma, Inc. (REPH) Q2 2020 Earnings Conference Call August 10, 2020 08:00 AM ET Company Participants Claudia Styslinger - Investor Relations Gerri Henwood - President and Chief Executive Officer Ryan Lake - Chief Financial Officer Conference Call Participants Lelan...
Gainers: Seres Therapeutics (NASDAQ: MCRB ) +356% . More news on: Seres Therapeutics, Inc., Xtant Medical Holdings, Inc., BiomX Inc., Stocks on the move, , Read more ...
Image source: The Motley Fool. Recro Pharma (NASDAQ: REPH) Q2 2020 Earnings Call Aug 10, 2020 , 8:00 a.m. ET Operator Continue reading
Nano cap Recro Pharma ( REPH -25.6% ) slumps on more than double normal volume after announcing less-than-expected Q2 results . Highlights: More news on: Recro Pharma, Inc., Healthcare stocks news, Stocks on the move, Earnings news and commentary, , Read more ...
Eastman Kodak (NYSE: KODK ) -39% after drug loan pause . More news on: Eastman Kodak Company, Neovasc Inc., Kazia Therapeutics Limited, Stocks on the move, , Read more ...
News, Short Squeeze, Breakout and More Instantly...
Societal CDMO to be Acquired by CoreRx, Inc. to Create an Enhanced CDMO with Broad Capabilities Spanning Early-Stage Formulation Development through Commercial Manufacturing and Packaging CoreRx to Commence a Tender Offer for all Outstanding Shares of Societal CDMO, Inc. CLEARWATE...
Agreement Broadly Applicable to All Therapeutic Areas with Specific Focus on the Growing Psychedelic and Cannabinoid Drug Development Markets Complementary Capabilities Range from API Manufacturing through Process Development and cGMP Manufacturing to Fill/Finish GAINESVILLE, Ga. ...
Recorded Q3 Revenue of $23.6 Million Signed Multiple New Business Agreements with New and Existing Customers Closed Public Offering Raising Gross Proceeds of Approximately $8.3 Million Initiated Corporate Restructuring; Expected to Result in Annualized Savings of Approxi...